Clinical trial · Observational
Dual Task Gait Performance in Pediatric Oncology Patients
Comparison of Single and Dual Task Gait Performance in Pediatric Oncology Patients With Healthy Control Group
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer incidence, which is recognized as the leading cause of death in children worldwide, is gradually increasing. Most studies on children who survive cancer show that the disease and its treatment have side effects and long-term late effects on the musculoskeletal system, physical function, gait and cognitive skills. Therefore, dual task gait performance, in which cognitive and motor tasks are performed simultaneously, may be affected in pediatric oncology patients. The aim of this study is to compare gait performance in single and dual task conditions in pediatric oncology patients with healthy controls.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dual tak gait assessment (motor+cognitive) | Other | — | UNRESOLVED |
| Dual task gait assessment (motor+motor) | Other | — | UNRESOLVED |
| Gait assessment (single) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Healthy Control Group
- description
- Healthy children who come to Afyonkarahisar Ege Youth and Sports Club Association for the purpose of sports, newly registered and between the ages of 6-18 will constitute the control group of the study.
- interventionNames
- Other: Gait assessment (single)
- Other: Dual task gait assessment (motor+motor)
- Other: Dual tak gait assessment (motor+cognitive)
- label
- Case Group
- description
- The sample of the study will be inpatient and outpatient pediatric patients between the ages of 6-18 who have been diagnosed with cancer in the Pediatric Hematology-Oncology Clinics of Afyonkarahisar Health Sciences University Health Application and Research Center Department of Pediatrics.
- interventionNames
- Other: Gait assessment (single)
- Other: Dual task gait assessment (motor+motor)
- Other: Dual tak gait assessment (motor+cognitive)
Primary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Healthy control group: * Being in the age range of 6-18, * To be physically, cognitively and mentally healthy, * Open to communication enough to understand questions, * Speaking and understanding Turkish, * Approval has been obtained from the child and his / her family for the study and who agrees to participate in the study, Case group: * Able to walk alone without any walking aid, * Open to communication enough to understand questions, * Speaking and understanding Turkish, * Approval has been obtained from the child and his / her family for the study and who agrees to participate in the study, * Children between the ages of 6-18 will be included in the study Exclusion Criteria: Healthy control group: * Any orthopedic or neurological impairment that would prevent walking; * Having any mental disability that prevents cognitive task Case group: * Staying in an isolated room or having risk of infection (neutropenic, etc.), * Any orthopedic or neurological impairment that could prevent walking; * Having any mental disability that prevents cognitive task, * Individuals with malignant hypertension or unstable heart disease (eg congestive heart failure) will not be included in the study.
References
Publications (0)
Data not yet available